title: Impact of puberty status and melengestrol acetate supplementation before the breeding period on reproductive efficiency of Bos indicus beef heifers.
abstract: Two experiments were designed to evaluate the impact of puberty status and the administration of melengestrol acetate (MGA) before onset of the breeding period on ovulatory responses (Exp. 1) and conception rate after AI performed on estrus detection during 10 d and the pregnancy rate through 80 d of breeding period (Exp. 2) of pasture-grazed beef heifers. In Exp. 1, heifers (15 pubertal and 15 prepubertal) received 0.5 mg per heifer/d -1 of MGA over 14 d. No differences in the ovulatory responses were found 10 d after the MGA administration (pubertal = 46.7% vs. prepubertal P = 53.3%; P = 0.72). In Exp. 2, 368 heifers were randomly assigned to groups according to pubertal status and the MGA treatment. All heifers were inseminated on estrus detection for up 10 d after MGA administration and following exposure to bulls between 20 and 80 d. The MGA-treated heifers exhibited a greater AI service rate than control heifers (72.1 vs. 41.6%;P < 0.01); however, heifers receiving MGA had lower conception results following AI (51.6 vs. 71.4%; P = 0.01). In addition, MGA-treated heifers were more likely to have a corpus luteum in the middle of the breeding period (95.3 vs. 87.5%;P < 0.01), although the Cox proportional hazard of pregnancy rate was similar (P = 0.29) at the end of the breeding period. At onset of the breeding period, pubertal heifers presented a greater pregnancy rate following AI (pubertal P = 42.2% vs. prepubertal P = 24.9%; P = 0.01). Therefore, pubertal heifers seem to have greater overall reproductive efficiency than prepubertal heifers, particularly at the beginning of the breeding period. Interestingly, administration of MGA before the onset of the breeding period increased AI service rate but did not alter the rate of pregnancy throughout the breeding period of pasture-grazed beef heifers.
authors.forename: J H
authors.initials: JH
authors.lastname: Martins
authors.forename: C S
authors.initials: CS
authors.lastname: Santos
authors.forename: M A V
authors.initials: MA
authors.lastname: Silva
authors.forename: H M V S B
authors.initials: HM
authors.lastname: Aguiar
authors.forename: I G
authors.initials: IG
authors.lastname: França
authors.forename: H G
authors.initials: HG
authors.lastname: Pereira
authors.forename: D L
authors.initials: DL
authors.lastname: Ribeiro
authors.forename: R M
authors.initials: RM
authors.lastname: Chaves
authors.forename: J A T
authors.initials: JA
authors.lastname: Souza
authors.forename: B M
authors.initials: BM
authors.lastname: Monteiro
authors.forename: M F
authors.initials: MF
authors.lastname: Sá Filho
authors.forename: J R S
authors.initials: JR
authors.lastname: Torres-Júnior
mesh_terms: D000818:Animals; D001947:Breeding / Q000379:methods*; D002417:Cattle; D019587:Dietary Supplements; D004972:Estrus Detection / Q000379:methods; D004973:Estrus Synchronization / Q000379:methods; D005260:Female; D005306:Fertilization / Q000187:drug effects; D007315:Insemination, Artificial / Q000662:veterinary; D008297:Male; D008552:Melengestrol Acetate / Q000008:administration & dosage / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects; D011247:Pregnancy; D018873:Pregnancy Rate; D011627:Puberty / Q000502:physiology*; D012098:Reproduction / Q000187:drug effects*
chemical_list: D008552:Melengestrol Acetate